Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 202

1.

Acquired acrodermatitis enteropathica due to zinc-depleted parenteral nutrition.

Wiznia LE, Bhansali S, Brinster N, Al-Qaqaa YM, Orlow SJ, Oza V.

Pediatr Dermatol. 2019 Jul;36(4):520-523. doi: 10.1111/pde.13865. Epub 2019 May 24.

PMID:
31124168
2.

Tinea incognito in an urban pediatric population.

Stringer T, Gittler JK, Orlow SJ.

Cutis. 2018 Nov;102(5):370-372.

PMID:
30566538
3.

Keratosis Pilaris and its Subtypes: Associations, New Molecular and Pharmacologic Etiologies, and Therapeutic Options.

Wang JF, Orlow SJ.

Am J Clin Dermatol. 2018 Oct;19(5):733-757. doi: 10.1007/s40257-018-0368-3. Review.

PMID:
30043128
4.

The Use of Hormonal Antiandrogen Therapy in Female Patients with Acne: A 10-Year Retrospective Study.

Park JH, Bienenfeld A, Orlow SJ, Nagler AR.

Am J Clin Dermatol. 2018 Jun;19(3):449-455. doi: 10.1007/s40257-018-0349-6.

PMID:
29556985
5.

Clinical evidence for washing and cleansers in acne vulgaris: a systematic review.

Stringer T, Nagler A, Orlow SJ, Oza VS.

J Dermatolog Treat. 2018 Nov;29(7):688-693. doi: 10.1080/09546634.2018.1442552. Epub 2018 Feb 25. Review.

PMID:
29460655
6.

Rapid improvement of prurigo nodularis with cyclosporine treatment.

Wiznia LE, Callahan SW, Cohen DE, Orlow SJ.

J Am Acad Dermatol. 2018 Jun;78(6):1209-1211. doi: 10.1016/j.jaad.2018.02.024. Epub 2018 Feb 10. No abstract available.

PMID:
29438756
7.

High-value dermatology: 5 Laboratory tests to reconsider.

Ogbechie-Godec OA, Wang JF, Feng H, Orlow SJ.

J Am Acad Dermatol. 2018 Jun;78(6):1232-1235. doi: 10.1016/j.jaad.2017.12.034. Epub 2017 Dec 19. Review. No abstract available.

PMID:
29273487
8.

Characterization of Herpes Simplex Virus Infections Seen in the Pediatric Dermatology Office.

Gittler JK, Mu EW, Orlow SJ.

Pediatr Dermatol. 2017 Jul;34(4):446-449. doi: 10.1111/pde.13190. Epub 2017 Jun 21.

PMID:
28636180
9.
10.

Oral Antibacterial Therapy for Acne Vulgaris: An Evidence-Based Review.

Bienenfeld A, Nagler AR, Orlow SJ.

Am J Clin Dermatol. 2017 Aug;18(4):469-490. doi: 10.1007/s40257-017-0267-z. Review.

PMID:
28255924
11.

Teens, Acne, and Oral Contraceptive Pills: The Need for Greater Clarity on When Teens Can Consent.

Neuhaus CP, Nagler AR, Orlow SJ.

JAMA Dermatol. 2017 Apr 1;153(4):249-250. doi: 10.1001/jamadermatol.2016.5096. Review. No abstract available.

PMID:
28097320
12.

Bathing and Associated Treatments in Atopic Dermatitis.

Gittler JK, Wang JF, Orlow SJ.

Am J Clin Dermatol. 2017 Feb;18(1):45-57. doi: 10.1007/s40257-016-0240-2. Review.

PMID:
27913962
13.

Recent advances in understanding vitiligo.

Manga P, Elbuluk N, Orlow SJ.

F1000Res. 2016 Sep 6;5. pii: F1000 Faculty Rev-2234. doi: 10.12688/f1000research.8976.1. eCollection 2016. Review.

14.

Cutaneous microbiome effects of fluticasone propionate cream and adjunctive bleach baths in childhood atopic dermatitis.

Gonzalez ME, Schaffer JV, Orlow SJ, Gao Z, Li H, Alekseyenko AV, Blaser MJ.

J Am Acad Dermatol. 2016 Sep;75(3):481-493.e8. doi: 10.1016/j.jaad.2016.04.066.

15.

Inhibition of the CRAF/prohibitin interaction reverses CRAF-dependent resistance to vemurafenib.

Doudican NA, Orlow SJ.

Oncogene. 2017 Jan 19;36(3):423-428. doi: 10.1038/onc.2016.214. Epub 2016 Jun 20.

PMID:
27321184
16.

Segmental stiff skin syndrome (SSS): A distinct clinical entity.

Myers KL, Mir A, Schaffer JV, Meehan SA, Orlow SJ, Brinster NK.

J Am Acad Dermatol. 2016 Jul;75(1):163-8. doi: 10.1016/j.jaad.2016.01.038. Epub 2016 Mar 2. Review.

PMID:
26944597
17.

Comparison of Childhood Vitiligo Presenting with or without Associated Halo Nevi.

Cohen BE, Mu EW, Orlow SJ.

Pediatr Dermatol. 2016 Jan-Feb;33(1):44-8. doi: 10.1111/pde.12717. Epub 2015 Nov 17.

PMID:
26573093
18.

The use of oral antibiotics before isotretinoin therapy in patients with acne.

Nagler AR, Milam EC, Orlow SJ.

J Am Acad Dermatol. 2016 Feb;74(2):273-9. doi: 10.1016/j.jaad.2015.09.046. Epub 2015 Oct 30.

PMID:
26525749
19.

Alternative Systemic Treatments for Vitiligo: A Review.

Cohen BE, Elbuluk N, Mu EW, Orlow SJ.

Am J Clin Dermatol. 2015 Dec;16(6):463-74. doi: 10.1007/s40257-015-0153-5. Review.

PMID:
26329814
20.

Early-onset childhood vitiligo is associated with a more extensive and progressive course.

Mu EW, Cohen BE, Orlow SJ.

J Am Acad Dermatol. 2015 Sep;73(3):467-70. doi: 10.1016/j.jaad.2015.05.038. Epub 2015 Jun 26.

PMID:
26118892
21.

Culinary Metaphors in Dermatology: Eating Our Words.

Milam EC, Mu EW, Orlow SJ.

JAMA Dermatol. 2015 Aug;151(8):912. doi: 10.1001/jamadermatol.2014.5416. No abstract available.

PMID:
25714065
22.
23.

Mucocutaneous granulomatous disease in a patient with Hermansky-Pudlak syndrome.

Salvaggio HL, Graeber KE, Clarke LE, Schlosser BJ, Orlow SJ, Clarke JT.

JAMA Dermatol. 2014 Oct;150(10):1083-7. doi: 10.1001/jamadermatol.2014.147. Review.

PMID:
24989352
24.

Genital melanocytic nevi in children: Experience in a pediatric dermatology practice.

Hunt RD, Orlow SJ, Schaffer JV.

J Am Acad Dermatol. 2014 Mar;70(3):429-34. doi: 10.1016/j.jaad.2013.10.022. Epub 2013 Dec 24.

PMID:
24373784
25.

Identification of agents that promote endoplasmic reticulum stress using an assay that monitors luciferase secretion.

Doudican NA, Wen SY, Mazumder A, Orlow SJ.

J Biomol Screen. 2014 Apr;19(4):575-84. doi: 10.1177/1087057113517549. Epub 2013 Dec 26.

26.

Cole Disease Results from Mutations in ENPP1.

Eytan O, Morice-Picard F, Sarig O, Ezzedine K, Isakov O, Li Q, Ishida-Yamamoto A, Shomron N, Goldsmith T, Fuchs-Telem D, Adir N, Uitto J, Orlow SJ, Taieb A, Sprecher E.

Am J Hum Genet. 2013 Oct 3;93(4):752-7. doi: 10.1016/j.ajhg.2013.08.007. Epub 2013 Sep 26.

27.

Loss of Oca2 disrupts the unfolded protein response and increases resistance to endoplasmic reticulum stress in melanocytes.

Cheng T, Orlow SJ, Manga P.

Pigment Cell Melanoma Res. 2013 Nov;26(6):826-34. doi: 10.1111/pcmr.12158. Epub 2013 Sep 9.

28.

IL-17 and TNF synergistically modulate cytokine expression while suppressing melanogenesis: potential relevance to psoriasis.

Wang CQF, Akalu YT, Suarez-Farinas M, Gonzalez J, Mitsui H, Lowes MA, Orlow SJ, Manga P, Krueger JG.

J Invest Dermatol. 2013 Dec;133(12):2741-2752. doi: 10.1038/jid.2013.237. Epub 2013 Apr 30.

29.

Evidence-based recommendations for the diagnosis and treatment of pediatric acne.

Eichenfield LF, Krakowski AC, Piggott C, Del Rosso J, Baldwin H, Friedlander SF, Levy M, Lucky A, Mancini AJ, Orlow SJ, Yan AC, Vaux KK, Webster G, Zaenglein AL, Thiboutot DM; American Acne and Rosacea Society.

Pediatrics. 2013 May;131 Suppl 3:S163-86. doi: 10.1542/peds.2013-0490B.

PMID:
23637225
30.

Cutaneous features of Crouzon syndrome with acanthosis nigricans.

Mir A, Wu T, Orlow SJ.

JAMA Dermatol. 2013 Jun;149(6):737-41. doi: 10.1001/jamadermatol.2013.3019. Review.

PMID:
23571469
31.

Spitz nevi: beliefs, behaviors, and experiences of pediatric dermatologists.

Tlougan BE, Orlow SJ, Schaffer JV.

JAMA Dermatol. 2013 Mar;149(3):283-91. doi: 10.1001/jamadermatol.2013.1124.

PMID:
23553063
32.

The Dermatology Foundation: partnerships and programs focused on the future.

Fairley JA, Krueger GG, Lessin SR, Leyden JJ, McBurney EI, Orlow SJ, Tharp MD, Voorhees JJ, Wintroub BU, Yancey KB.

J Invest Dermatol. 2013 Apr;133(4):861-2. doi: 10.1038/jid.2013.15. No abstract available.

33.

XIAP downregulation accompanies mebendazole growth inhibition in melanoma xenografts.

Doudican NA, Byron SA, Pollock PM, Orlow SJ.

Anticancer Drugs. 2013 Feb;24(2):181-8. doi: 10.1097/CAD.0b013e32835a43f1.

PMID:
23059386
34.

Sulforaphane synergistically enhances the cytotoxicity of arsenic trioxide in multiple myeloma cells via stress-mediated pathways.

Doudican NA, Wen SY, Mazumder A, Orlow SJ.

Oncol Rep. 2012 Nov;28(5):1851-8. doi: 10.3892/or.2012.1977. Epub 2012 Aug 22.

35.

Experience with molluscum contagiosum and associated inflammatory reactions in a pediatric dermatology practice: the bump that rashes.

Berger EM, Orlow SJ, Patel RR, Schaffer JV.

Arch Dermatol. 2012 Nov;148(11):1257-64. doi: 10.1001/archdermatol.2012.2414.

PMID:
22911012
36.

Vitiligo-inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8.

Toosi S, Orlow SJ, Manga P.

J Invest Dermatol. 2012 Nov;132(11):2601-9. doi: 10.1038/jid.2012.181. Epub 2012 Jun 14.

37.

Engineering a new mouse model for vitiligo.

Manga P, Orlow SJ.

J Invest Dermatol. 2012 Jul;132(7):1752-5. doi: 10.1038/jid.2012.140.

38.

Albendazole sensitizes cancer cells to ionizing radiation.

Patel K, Doudican NA, Schiff PB, Orlow SJ.

Radiat Oncol. 2011 Nov 17;6:160. doi: 10.1186/1748-717X-6-160.

39.

Abortive segmental perineal hemangioma.

Tlougan BE, Gonzalez ME, Orlow SJ.

Dermatol Online J. 2011 Oct 15;17(10):8.

PMID:
22031634
40.

Radiation therapy for high-risk squamous cell carcinomas in patients with xeroderma pigmentosum: report of two cases and review of the literature.

Schaffer JV, Orlow SJ.

Dermatology. 2011;223(2):97-103. doi: 10.1159/000324509. Epub 2011 Oct 21. Review.

PMID:
22024645
41.

Informed reasoning: repositioning of nitisinone to treat oculocutaneous albinism.

Manga P, Orlow SJ.

J Clin Invest. 2011 Oct;121(10):3828-31. doi: 10.1172/JCI59763.

42.

Fluvastatin enhances sorafenib cytotoxicity in melanoma cells via modulation of AKT and JNK signaling pathways.

Zhang S, Doudican NA, Quay E, Orlow SJ.

Anticancer Res. 2011 Oct;31(10):3259-65.

PMID:
21965734
43.

Patient-reported outcomes in pediatric patients with psoriasis undergoing etanercept treatment: 12-week results from a phase III randomized controlled trial.

Langley RG, Paller AS, Hebert AA, Creamer K, Weng HH, Jahreis A, Globe D, Patel V, Orlow SJ.

J Am Acad Dermatol. 2011 Jan;64(1):64-70. doi: 10.1016/j.jaad.2010.02.060. Epub 2010 Jul 8.

PMID:
20619489
44.

The unfolded protein response in melanocytes: activation in response to chemical stressors of the endoplasmic reticulum and tyrosinase misfolding.

Manga P, Bis S, Knoll K, Perez B, Orlow SJ.

Pigment Cell Melanoma Res. 2010 Oct;23(5):627-34. doi: 10.1111/j.1755-148X.2010.00718.x. Epub 2010 Apr 23.

45.

Undifferentiated pleomorphic sarcoma in a child with type 1 neurofibromatosis.

Patel RR, Meehan S, Orlow SJ.

Br J Dermatol. 2010 Aug;163(2):431-3. doi: 10.1111/j.1365-2133.2010.09818.x. Epub 2010 Apr 23. No abstract available.

PMID:
20426779
46.

Androgenetic alopecia in the paediatric population: a retrospective review of 57 patients.

Gonzalez ME, Cantatore-Francis J, Orlow SJ.

Br J Dermatol. 2010 Aug;163(2):378-85. doi: 10.1111/j.1365-2133.2010.09777.x. Epub 2010 Mar 23.

PMID:
20346026
47.

Morphea, diabetes mellitus type I, and celiac disease: case report and review of the literature.

Firoz EF, Kamino H, Lehman TJ, Orlow SJ.

Pediatr Dermatol. 2010 Jan-Feb;27(1):48-52. doi: 10.1111/j.1525-1470.2009.00907.x. Review.

PMID:
20199410
48.

Developing a multidisciplinary prospective melanoma biospecimen repository to advance translational research.

Wich LG, Hamilton HK, Shapiro RL, Pavlick A, Berman RS, Polsky D, Goldberg JD, Hernando E, Manga P, Krogsgaard M, Kamino H, Darvishian F, Lee P, Orlow SJ, Ostrer H, Bhardwaj N, Osman I.

Am J Transl Res. 2009;1(1):35-43. Epub 2009 Jan 1.

49.

Disulfiram induces copper-dependent stimulation of reactive oxygen species and activation of the extrinsic apoptotic pathway in melanoma.

Morrison BW, Doudican NA, Patel KR, Orlow SJ.

Melanoma Res. 2010 Feb;20(1):11-20. doi: 10.1097/CMR.0b013e328334131d.

PMID:
19966593
50.

Celastrol synergistically enhances temozolomide cytotoxicity in melanoma cells.

Chen M, Rose AE, Doudican N, Osman I, Orlow SJ.

Mol Cancer Res. 2009 Dec;7(12):1946-53. doi: 10.1158/1541-7786.MCR-09-0243. Epub 2009 Nov 24.

Supplemental Content

Loading ...
Support Center